OTCMKTS:RDSMY

Koninklijke DSM Competitors

$45.72
-0.66 (-1.42 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$45.63
$46.38
50-Day Range
$42.57
$46.98
52-Week Range
$29.39
$46.98
Volume48,952 shs
Average Volume34,435 shs
Market Capitalization$33.18 billion
P/E Ratio49.70
Dividend Yield1.20%
Beta0.84

Competitors

Koninklijke DSM (OTCMKTS:RDSMY) Vs. BASFY, AHKSY, FMC, JMPLY, OLN, and HUN

Should you be buying RDSMY stock or one of its competitors? Companies in the industry of "chemicals & allied products" are considered alternatives and competitors to Koninklijke DSM, including Basf (BASFY), Asahi Kasei (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), Olin (OLN), and Huntsman (HUN).

Basf (OTCMKTS:BASFY) and Koninklijke DSM (OTCMKTS:RDSMY) are both large-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Volatility & Risk

Basf has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Valuation & Earnings

This table compares Basf and Koninklijke DSM's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Basf$66.44 billion1.18$9.43 billion$1.1219.07
Koninklijke DSM$10.09 billion3.29$848.96 million$1.3035.17

Basf has higher revenue and earnings than Koninklijke DSM. Basf is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Dividends

Basf pays an annual dividend of $0.70 per share and has a dividend yield of 3.3%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Basf pays out 62.5% of its earnings in the form of a dividend. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Basf and Koninklijke DSM's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Basf-3.55%6.52%2.90%
Koninklijke DSM6.66%9.81%5.27%

Institutional & Insider Ownership

0.2% of Basf shares are held by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for Basf and Koninklijke DSM, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Basf131002.64
Koninklijke DSM11602.63

Koninklijke DSM (OTCMKTS:RDSMY) and Asahi Kasei (OTCMKTS:AHKSY) are both large-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.

Volatility & Risk

Koninklijke DSM has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Asahi Kasei has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.

Insider and Institutional Ownership

0.1% of Koninklijke DSM shares are held by institutional investors. Comparatively, 0.1% of Asahi Kasei shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Koninklijke DSM and Asahi Kasei's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke DSM$10.09 billion3.29$848.96 million$1.3035.17
Asahi Kasei$19.76 billion0.78$956.16 million$1.7412.63

Asahi Kasei has higher revenue and earnings than Koninklijke DSM. Asahi Kasei is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Dividends

Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Asahi Kasei pays an annual dividend of $0.48 per share and has a dividend yield of 2.2%. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Asahi Kasei pays out 27.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Asahi Kasei is clearly the better dividend stock, given its higher yield and lower payout ratio.

Profitability

This table compares Koninklijke DSM and Asahi Kasei's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Koninklijke DSM6.66%9.81%5.27%
Asahi Kasei4.05%8.80%4.44%

Analyst Ratings

This is a summary of current recommendations for Koninklijke DSM and Asahi Kasei, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Koninklijke DSM11602.63
Asahi Kasei01013.00

Summary

Asahi Kasei beats Koninklijke DSM on 8 of the 15 factors compared between the two stocks.

FMC (NYSE:FMC) and Koninklijke DSM (OTCMKTS:RDSMY) are both large-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.

Insider and Institutional Ownership

87.4% of FMC shares are held by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are held by institutional investors. 1.0% of FMC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk & Volatility

FMC has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, Koninklijke DSM has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

Earnings & Valuation

This table compares FMC and Koninklijke DSM's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FMC$4.61 billion3.27$477.40 million$6.0919.14
Koninklijke DSM$10.09 billion3.29$848.96 million$1.3035.17

Koninklijke DSM has higher revenue and earnings than FMC. FMC is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares FMC and Koninklijke DSM's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
FMC10.64%30.81%8.57%
Koninklijke DSM6.66%9.81%5.27%

Dividends

FMC pays an annual dividend of $1.92 per share and has a dividend yield of 1.6%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. FMC pays out 31.5% of its earnings in the form of a dividend. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. FMC has raised its dividend for 1 consecutive years. FMC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Ratings

This is a breakdown of current ratings and target prices for FMC and Koninklijke DSM, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
FMC05902.64
Koninklijke DSM11602.63

FMC currently has a consensus price target of $129.3333, suggesting a potential upside of 10.87%. Given FMC's stronger consensus rating and higher probable upside, research analysts plainly believe FMC is more favorable than Koninklijke DSM.

Summary

FMC beats Koninklijke DSM on 13 of the 17 factors compared between the two stocks.

Koninklijke DSM (OTCMKTS:RDSMY) and Johnson Matthey (OTCMKTS:JMPLY) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Institutional and Insider Ownership

0.1% of Koninklijke DSM shares are held by institutional investors. Comparatively, 0.0% of Johnson Matthey shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Koninklijke DSM and Johnson Matthey, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Koninklijke DSM11602.63
Johnson Matthey34602.23

Dividends

Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Koninklijke DSM and Johnson Matthey's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Koninklijke DSM6.66%9.81%5.27%
Johnson MattheyN/AN/AN/A

Risk & Volatility

Koninklijke DSM has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

Valuation and Earnings

This table compares Koninklijke DSM and Johnson Matthey's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke DSM$10.09 billion3.29$848.96 million$1.3035.17
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.04

Koninklijke DSM has higher earnings, but lower revenue than Johnson Matthey. Johnson Matthey is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Summary

Koninklijke DSM beats Johnson Matthey on 9 of the 13 factors compared between the two stocks.

Olin (NYSE:OLN) and Koninklijke DSM (OTCMKTS:RDSMY) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Risk and Volatility

Olin has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500.

Profitability

This table compares Olin and Koninklijke DSM's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Olin-18.47%-9.98%-2.34%
Koninklijke DSM6.66%9.81%5.27%

Institutional & Insider Ownership

84.7% of Olin shares are owned by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are owned by institutional investors. 11.7% of Olin shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dividends

Olin pays an annual dividend of $0.80 per share and has a dividend yield of 1.7%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Olin pays out 133.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Olin has increased its dividend for 1 consecutive years. Olin is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation & Earnings

This table compares Olin and Koninklijke DSM's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Olin$6.11 billion1.21$-11,300,000.00$0.6077.38
Koninklijke DSM$10.09 billion3.29$848.96 million$1.3035.17

Koninklijke DSM has higher revenue and earnings than Olin. Koninklijke DSM is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Olin and Koninklijke DSM, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Olin04902.69
Koninklijke DSM11602.63

Olin currently has a consensus target price of $43.1538, suggesting a potential downside of 6.53%. Given Olin's stronger consensus rating and higher probable upside, analysts clearly believe Olin is more favorable than Koninklijke DSM.

Summary

Koninklijke DSM beats Olin on 9 of the 17 factors compared between the two stocks.

Huntsman (NYSE:HUN) and Koninklijke DSM (OTCMKTS:RDSMY) are both basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Volatility and Risk

Huntsman has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Profitability

This table compares Huntsman and Koninklijke DSM's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Huntsman16.55%5.27%2.06%
Koninklijke DSM6.66%9.81%5.27%

Insider & Institutional Ownership

77.3% of Huntsman shares are held by institutional investors. Comparatively, 0.1% of Koninklijke DSM shares are held by institutional investors. 5.4% of Huntsman shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Huntsman and Koninklijke DSM's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Huntsman$6.80 billion1.00$562 million$1.5320.14
Koninklijke DSM$10.09 billion3.29$848.96 million$1.3035.17

Koninklijke DSM has higher revenue and earnings than Huntsman. Huntsman is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Dividends

Huntsman pays an annual dividend of $0.65 per share and has a dividend yield of 2.1%. Koninklijke DSM pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. Huntsman pays out 42.5% of its earnings in the form of a dividend. Koninklijke DSM pays out 43.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has increased its dividend for 1 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Analyst Ratings

This is a summary of current ratings and target prices for Huntsman and Koninklijke DSM, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Huntsman031202.80
Koninklijke DSM11602.63

Huntsman presently has a consensus price target of $30.6875, suggesting a potential downside of 0.88%. Given Huntsman's stronger consensus rating and higher possible upside, analysts plainly believe Huntsman is more favorable than Koninklijke DSM.

Summary

Huntsman beats Koninklijke DSM on 11 of the 17 factors compared between the two stocks.


Koninklijke DSM Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Basf logo
BASFY
Basf
1.3$21.36-0.2%$78.47 billion$66.44 billion-33.90News Coverage
Asahi Kasei logo
AHKSY
Asahi Kasei
1.5$21.97-0.8%$15.43 billion$19.76 billion19.62Gap Up
FMC logo
FMC
FMC
2.4$116.56-1.5%$15.33 billion$4.61 billion30.51Earnings Announcement
Analyst Revision
Johnson Matthey logo
JMPLY
Johnson Matthey
1.4$91.47-0.0%$8.85 billion$18.53 billion18.04
Olin logo
OLN
Olin
1.6$46.43-2.0%$7.25 billion$6.11 billion-7.22Analyst Report
Insider Selling
Gap Down
Huntsman logo
HUN
Huntsman
2.3$30.81-0.8%$6.88 billion$6.80 billion6.94Analyst Report
Gap Down
The Chemours logo
CC
The Chemours
1.9$34.20-0.2%$5.65 billion$5.53 billion-47.50Analyst Report
Analyst Revision
Gap Down
Ashland Global logo
ASH
Ashland Global
1.8$86.99-1.0%$5.33 billion$2.33 billion-10.36Analyst Report
W. R. Grace & Co. logo
GRA
W. R. Grace & Co.
2.2$68.33-0.1%$4.53 billion$1.96 billion325.38Earnings Announcement
Balchem logo
BCPC
Balchem
1.6$130.59-0.9%$4.20 billion$643.71 million51.21
Univar Solutions logo
UNVR
Univar Solutions
1.1$26.18-5.4%$4.20 billion$9.29 billion145.45Earnings Announcement
Analyst Upgrade
News Coverage
Showa Denko K.K. logo
SHWDY
Showa Denko K.K.
0.5$27.76-0.0%$4.05 billion$8.27 billion-6.44News Coverage
Kuraray logo
KURRY
Kuraray
0.9$33.67-0.0%$3.98 billion$5.26 billion-71.64Upcoming Earnings
News Coverage
Ingevity logo
NGVT
Ingevity
1.7$86.60-0.1%$3.47 billion$1.29 billion20.09Analyst Report
Insider Selling
Livent logo
LTHM
Livent
1.3$17.61-0.3%$2.59 billion$388.40 million-195.67Gap Down
Innospec logo
IOSP
Innospec
1.8$101.34-0.9%$2.47 billion$1.51 billion68.01Earnings Announcement
Dividend Increase
Gap Down
PQ Group logo
PQG
PQ Group
1.7$15.28-0.2%$2.10 billion$1.57 billion47.75Earnings Announcement
Analyst Report
News Coverage
GCP Applied Technologies logo
GCP
GCP Applied Technologies
1.5$26.10-0.1%$1.91 billion$1.01 billion18.13
Hawkins logo
HWKN
Hawkins
2.0$33.26-0.6%$710.09 million$540.20 million10.59Gap Down
Loop Industries logo
LOOP
Loop Industries
1.4$8.27-1.9%$343.98 millionN/A-19.69
Liquidmetal Technologies logo
LQMT
Liquidmetal Technologies
0.8$0.08-0.0%$75.95 million$1.37 million0.00
GURE
Gulf Resources
0.6$6.64-1.2%$66.39 million$10.60 million0.00
ESP Resources logo
ESPIQ
ESP Resources
0.0$0.01-1.1%$2.35 millionN/A0.00
GETG
Green Earth Technologies
0.5$0.00-0.0%$0.00N/A0.00
ISON
Isonics
0.0$0.00-0.0%$0.00N/A0.00
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.